Pharmaceutical

Tempus AI expands oncology collaboration with Takeda

Tempus AI has announced an expanded collaboration with Takeda to enhance oncology research and development.

Sep 28, 2024 - 04:00
Tempus AI expands oncology collaboration with Takeda
Tempus AI has announced an expanded collaboration with Takeda to enhance oncology research and development.
Read the original article

Tags:

Previous Article

API Chemical Contract Manufacturing Companies for the Pharmaceutical Industry

Next Article

Phare Bio receives ARPA-H funds for AI drug discovery platform

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Drugmakers agree to negotiate Medicare prices under protest; AstraZeneca settles lawsuits over heartburn drugs

STAT+: Pharmalittle: Drugmakers agree to negotiate Medi...

Oct 4, 2023

Silence Therapeutics gets grant for compound for rna interference therapy in treating liver disease

Silence Therapeutics gets grant for compound for rna in...

Jun 12, 2024

CPHI Europe: Overcoming the unique challenges with high-concentration mAbs

CPHI Europe: Overcoming the unique challenges with high...

Oct 12, 2024